Open AccessOxaliplatin and Leucovorin Plus Fluorouracil Versus Irinotecan and Leucovorin Plus Fluorouracil Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Adenocarcinoma
Author(s) -
Sun Hyung Kang,
Jeong Il Kim,
Hee Seok Moon,
Seok Hyun Kim,
Jae Kyu Sung,
Byung Seok Lee,
Hyun Yong Jeong
Publication year - 2010
Publication title -
korean journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.203
H-Index - 25
eISSN - 2233-6869
pISSN - 1598-9992
DOI - 10.4166/kjg.2010.55.1.26
Subject(s) - irinotecan , oxaliplatin , medicine , folfiri , folfox , fluorouracil , chemotherapy , gastroenterology , adenocarcinoma , folinic acid , oncology , colorectal cancer , surgery , cancer
We performed retrospective study in order to compare oxaliplatin, leucovorin, and fluorouracil (FOLFOX) versus irinotecan, leucovorin, and fluorouracil (FOLFIRI) in recurred or metastatic gastric adenocarcinoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom